西藏药业：2025年半年度公司实现营业收入1650705155.36元

Group 1 - The core point of the article is that Tibet Pharmaceutical announced its financial results for the first half of 2025, showing a slight increase in revenue but a decline in net profit [1] - The company achieved operating revenue of 1,650,705,155.36 yuan, representing a year-on-year growth of 2.23% [1] - The net profit attributable to shareholders of the listed company was 567,323,117.52 yuan, which reflects a year-on-year decrease of 8.96% [1]